We compared allele frequencies of MITF (E318K) for the familial (MAF = 0.6%) and sporadic (MAF = 0.6%) melanoma cohorts and did not observe any difference, suggesting that the sporadic cohort should be powerful enough to detect primary cancer risks associated with MITF(E318K). Here, MITF is linked to cancer.